Literature DB >> 23538419

Analysis of the oligomeric state and transactivation potential of TAp73α.

L M Luh1, S Kehrloesser, G B Deutsch, J Gebel, D Coutandin, B Schäfer, M Agostini, G Melino, V Dötsch.   

Abstract

The proteins p73 and p63 are members of the p53 protein family and are involved in important developmental processes. Their high sequence identity with the tumor suppressor p53 has suggested that they act as tumor suppressors as well. While p63 has a crucial role in the maintenance of epithelial stem cells and in the quality control of oocytes without a clear role as a tumor suppressor, p73's tumor suppressor activity is well documented. In a recent study we have shown that the transcriptional activity of TAp63α, the isoform responsible for the quality control in oocytes, is regulated by its oligomeric state. The protein forms an inactive, dimeric and compact conformation in resting oocytes, while the detection of DNA damage leads to the formation of an active, tetrameric and open conformation. p73 shows a high sequence identity to p63, including those domains that are crucial in stabilizing its inactive state, thus suggesting that p73's activity might be regulated by its oligomeric state as well. Here, we have investigated the oligomeric state of TAp73α by size exclusion chromatography and detailed domain interaction mapping, and show that in contrast to p63, TAp73α is a constitutive open tetramer. However, its transactivation potential depends on the cellular background and the promoter context. These results imply that the regulation of p73's transcriptional activity might be more closely related to p53 than to p63.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538419      PMCID: PMC3705593          DOI: 10.1038/cdd.2013.23

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

Review 2.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

3.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

4.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

5.  Tracing the protectors path from the germ line to the genome.

Authors:  Daniel Coutandin; Horng Der Ou; Frank Löhr; Volker Dötsch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

Review 6.  p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.

Authors:  G Melino
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

7.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

8.  Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

Authors:  R Agami; G Blandino; M Oren; Y Shaul
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

9.  Structure and kinetic stability of the p63 tetramerization domain.

Authors:  Eviatar Natan; Andreas C Joerger
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

10.  Pin1 links the activities of c-Abl and p300 in regulating p73 function.

Authors:  Fiamma Mantovani; Silvano Piazza; Monica Gostissa; Sabrina Strano; Paola Zacchi; Roberto Mantovani; Giovanni Blandino; Giannino Del Sal
Journal:  Mol Cell       Date:  2004-06-04       Impact factor: 17.970

View more
  27 in total

1.  p73 - constitutively open for business.

Authors:  M A Seeliger; U M Moll
Journal:  Cell Death Differ       Date:  2013-08       Impact factor: 15.828

Review 2.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

3.  CHK2 sets the stage for CK1 in oocyte quality control.

Authors:  Sebastian Kehrloesser; Marcel Tuppi; Volker Dötsch
Journal:  Cell Death Differ       Date:  2018-06       Impact factor: 15.828

Review 4.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

5.  Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Authors:  Sebastian Kehrloesser; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Karen Heather Vousden; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

6.  Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.

Authors:  Hesham M Hassan; Michelle L Varney; Nagendra K Chaturvedi; Shantaram S Joshi; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2016-04-13

7.  Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.

Authors:  Jakob Gebel; Laura M Luh; Daniel Coutandin; Christian Osterburg; Frank Löhr; Birgit Schäfer; Ann-Sophie Frombach; Manuela Sumyk; Lena Buchner; Tobias Krojer; Eidarus Salah; Sebastian Mathea; Peter Güntert; Stefan Knapp; Volker Dötsch
Journal:  Cell Death Differ       Date:  2016-10-07       Impact factor: 15.828

Review 8.  Structural Evolution and Dynamics of the p53 Proteins.

Authors:  Giovanni Chillemi; Sebastian Kehrloesser; Francesca Bernassola; Alessandro Desideri; Volker Dötsch; Arnold J Levine; Gerry Melino
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 9.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

10.  p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Authors:  Sonia Melino; Alessia Bellomaria; Ridvan Nepravishta; Maurizio Paci; Gerry Melino
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.